Back to User profile » Dr Luca Boni
Paper published by Dr Luca Boni:
Original Research
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/wJZR_fRXUwg/1.jpg)
Muratori L, Petroni G, Antonuzzo L, Boni L, Iorio J, Lastraioli E, Bartoli G, Messerini L, Di Costanzo F, Arcangeli A
OncoTargets and Therapy 2016, 9:6325-6332
Published Date: 14 October 2016